+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Left Ventricular Assist Devices - Medical Devices Pipeline Assessment, 2020

  • ID: 5149970
  • Report
  • September 2020
  • Region: Global
  • 129 pages
  • GlobalData

FEATURED COMPANIES

  • Abbott Laboratories
  • Cleveland Clinic Hospital
  • Everheart Systems, LLC
  • Lonestar Heart Inc
  • PlugMed Heart SAS
  • U.S. Stem Cell Inc
  • MORE
Summary

The publisher's Medical Devices sector report, “Left Ventricular Assist Devices - Medical Devices Pipeline Assessment, 2020" provides comprehensive information about the Left Ventricular Assist Devices pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

An implantable left ventricular assist device is a ventricular assist system intended for the treatment of end-stage heart failure.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope
  • Extensive coverage of the Left Ventricular Assist Devices under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Left Ventricular Assist Devices and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry
Reasons to Buy

The report enables you to -
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Left Ventricular Assist Devices under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Abbott Laboratories
  • Cleveland Clinic Hospital
  • Everheart Systems, LLC
  • Lonestar Heart Inc
  • PlugMed Heart SAS
  • U.S. Stem Cell Inc
  • MORE
1 Table of Contents
1.1 List of Tables
1.2 List of Figures

2 Introduction
2.1 Left Ventricular Assist Devices Overview

3 Products under Development
3.1 Left Ventricular Assist Devices - Pipeline Products by Stage of Development
3.2 Left Ventricular Assist Devices - Pipeline Products by Territory
3.3 Left Ventricular Assist Devices - Pipeline Products by Regulatory Path
3.4 Left Ventricular Assist Devices - Pipeline Products by Estimated Approval Date
3.5 Left Ventricular Assist Devices - Ongoing Clinical Trials

4 Left Ventricular Assist Devices - Pipeline Products under Development by Companies
4.1 Left Ventricular Assist Devices Companies - Pipeline Products by Stage of Development
4.2 Left Ventricular Assist Devices - Pipeline Products by Stage of Development

5 Left Ventricular Assist Devices Companies and Product Overview

6 Left Ventricular Assist Devices - Recent Developments

7 Appendix

List of Tables
Table 1: Left Ventricular Assist Devices - Pipeline Products by Stage of Development
Table 2: Left Ventricular Assist Devices - Pipeline Products by Territory
Table 3: Left Ventricular Assist Devices - Pipeline Products by Regulatory Path
Table 4: Left Ventricular Assist Devices - Pipeline Products by Estimated Approval Date
Table 5: Left Ventricular Assist Devices - Ongoing Clinical Trials
Table 6: Left Ventricular Assist Devices Companies - Pipeline Products by Stage of Development
Table 7: Left Ventricular Assist Devices - Pipeline Products by Stage of Development
Table 8: Abbott Laboratories Pipeline Products & Ongoing Clinical Trials Overview
Table 9: Fully Implantable Left Ventricular Assist System - Product Status
Table 10: Fully Implantable Left Ventricular Assist System - Product Description
Table 11: Abiomed Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 12: Impella 5.5 With SmartAssist - Product Status
Table 13: Impella 5.5 With SmartAssist - Product Description
Table 14: Impella BTR - Product Status
Table 15: Impella BTR - Product Description
Table 16: Impella ECP - Product Status
Table 17: Impella ECP - Product Description
Table 18: Next Generation Impella CP - STEMI - Product Status
Table 19: Next Generation Impella CP - STEMI - Product Description
Table 20: Abiomed Inc - Ongoing Clinical Trials Overview
Table 21: Impella ECP - Use of the Impella ECP in Patients Undergoing an Elective High-risk Percutaneous Coronary Intervention: An Early Feasibility Study
Table 22: Next Generation Impella CP - STEMI - Primary Unloading and Delayed Reperfusion in St-elevation Myocardial Infarction: The STEMI-DTU Trial
Table 23: Arrow International Cr, A.S. Pipeline Products & Ongoing Clinical Trials Overview
Table 24: CorAide Left Ventricular Assist System - Product Status
Table 25: CorAide Left Ventricular Assist System - Product Description
Table 26: BioVentrix Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 27: PliCath HF - Product Status
Table 28: PliCath HF - Product Description
Table 29: Calon Cardio-Technology Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 30: Calon MiniVAD - Product Status
Table 31: Calon MiniVAD - Product Description
Table 32: MicroVAD - Product Status
Table 33: MicroVAD - Product Description
Table 34: CardiacBooster BV Pipeline Products & Ongoing Clinical Trials Overview
Table 35: Percutaneous Ventricular Assist Device - Product Status
Table 36: Percutaneous Ventricular Assist Device - Product Description
Table 37: CARDIAnove Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 38: CARDIAnove Pump - Product Status
Table 39: CARDIAnove Pump - Product Description
Table 40: Carnegie Mellon University Pipeline Products & Ongoing Clinical Trials Overview

List of Figures
Figure 1: Left Ventricular Assist Devices - Pipeline Products by Stage of Development
Figure 2: Left Ventricular Assist Devices - Pipeline Products by Territory
Figure 3: Left Ventricular Assist Devices - Pipeline Products by Regulatory Path
Figure 4: Left Ventricular Assist Devices - Pipeline Products by Estimated Approval Date
Figure 5: Left Ventricular Assist Devices - Ongoing Clinical Trials
Note: Product cover images may vary from those shown
  • Abbott Laboratories
  • Abiomed Inc
  • Arrow International Cr, A.S.
  • BioVentrix Inc
  • Calon Cardio-Technology Ltd
  • CardiacBooster BV
  • CARDIAnove Inc
  • Carnegie Mellon University
  • Cleveland Clinic Hospital
  • Cleveland Heart Inc
  • CorAssist Cardiovascular Ltd
  • CorWave
  • Duke University
  • Evaheart Inc
  • Everheart Systems, LLC
  • FineHeart
  • HeartWare International Inc
  • Inspired Therapeutics LLC
  • Jarvik Heart Inc
  • LaunchPoint Technologies Inc
  • Leviticus Cardio Ltd
  • Levram Medical Systems Ltd
  • Lonestar Heart Inc
  • Mayo Clinic
  • Medtronic Plc
  • Nipro Corp
  • Perfusion Solution Inc
  • PlugMed Heart SAS
  • Procyrion Inc
  • ReliantHeart, Inc.
  • Sree Chitra Tirunal Institute for Medical Sciences & Technology
  • Sunshine Heart Company, Pty. Ltd.
  • Terumo Corp
  • Thoratec LLC
  • Tokyo Medical and Dental University
  • U.S. Stem Cell Inc
  • University of Virginia
  • VASCOR Inc
  • Windmill Cardiovascular Systems, Inc.
  • W-Z BIOTECH, LLC
  • Yale University
Note: Product cover images may vary from those shown
Adroll
adroll